The response rate is higher. 4/4 100% of the patients who received 400mg in phase 1b dose escalation trial received a PR….
2 at 40% shrinkage 1 at 60% shrinkage 1 at 80% shrinkage of tumour.
Small n, but if this continues over the 50 patients its a company maker
